On July 31, 2023, The Longreach Group announced that it had, together with the founder family minority shareholders, completed the sale of all the issued and outstanding shares in Quasar Medical to funds managed by Boyu Capital. The deal value was not disclosed. Wilson Sonsini Goodrich & Rosati represented Boyu Capital in this acquisition.
Quasar Medical is a contract development and manufacturing organization for the medical device industry, servicing leading global OEMs such as Johnson & Johnson and Medtronic and specializing in the assembly of complex, minimally invasive components and devices across therapeutic areas with a focus on the cardiology space. Quasar is headquartered in Hong Kong, with assembly facilities in China, Thailand, and Singapore and R&D resources in Israel.
The Wilson Sonsini team that advised Boyu Capital in the transaction includes:
Mergers & Acquisitions
Weiheng Chen
Xuchao Dong
Chun Teng
Athena Yu
Yiwen Feng
Yang Liao
Technology Transactions
Chi-Fei Wang
Tony Nguyen
Regulatory and Compliance
Stephen R. Heifetz
Eva F. Yin
Jahna Hartwig
Patents and Innovations
Richard Wang
Litigation
Sheryl Shapiro Bassin
Draco Ng
Paul C. Gross
Derivatives
Andrew Ralston
Alex Weber
Delaware Corporate
Adrian Broderick
Sara Pollock
For more information, please see Longreach Group’s press release.